The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Oncology Injection Drug-Global Market Insights and Sales Trends 2025

Oncology Injection Drug-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1809283

No of Pages : 118

Ask Your Query
Synopsis
An oncology injection drug refers to a medication administered by injection for the treatment of cancer. These drugs can be chemotherapy agents, targeted therapies, immunotherapies, or supportive medications.
The global Oncology Injection Drug market size is expected to reach US$ 244 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Oncology Injection Drug in various end use industries. The expanding demands from the Lymphoma, Myeloma, Prostate Cancer and Other, are propelling Oncology Injection Drug market. Organs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Central Nervous System segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oncology Injection Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oncology Injection Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oncology Injection Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oncology Injection Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oncology Injection Drug covered in this report include Taj Oncology, S.G. Biopharm, AdvaCare, Merrimack, Celgene, Allos Therapeutics, Ferring Pharmaceuticals, Genzyme and Eli Lilly, etc.
The global Oncology Injection Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience
Global Oncology Injection Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oncology Injection Drug market, Segment by Type:
Organs
Central Nervous System
Circulatory/Musculoskeletal System
Other
Global Oncology Injection Drug market, by Application
Lymphoma
Myeloma
Prostate Cancer
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oncology Injection Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oncology Injection Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Oncology Injection Drug Market Overview
1.1 Oncology Injection Drug Product Overview
1.2 Oncology Injection Drug Market Segment by Type
1.2.1 Organs
1.2.2 Central Nervous System
1.2.3 Circulatory/Musculoskeletal System
1.2.4 Other
1.3 Global Oncology Injection Drug Market Size by Type
1.3.1 Global Oncology Injection Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Oncology Injection Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oncology Injection Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oncology Injection Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oncology Injection Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oncology Injection Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oncology Injection Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oncology Injection Drug Sales Breakdown by Type (2018-2023)
2 Global Oncology Injection Drug Market Competition by Company
2.1 Global Top Players by Oncology Injection Drug Sales (2018-2023)
2.2 Global Top Players by Oncology Injection Drug Revenue (2018-2023)
2.3 Global Top Players by Oncology Injection Drug Price (2018-2023)
2.4 Global Top Manufacturers Oncology Injection Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oncology Injection Drug Market Competitive Situation and Trends
2.5.1 Oncology Injection Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oncology Injection Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Oncology Injection Drug Market
2.8 Key Manufacturers Oncology Injection Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oncology Injection Drug Status and Outlook by Region
3.1 Global Oncology Injection Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oncology Injection Drug Historic Market Size by Region
3.2.1 Global Oncology Injection Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Oncology Injection Drug Sales in Value by Region (2018-2023)
3.2.3 Global Oncology Injection Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oncology Injection Drug Forecasted Market Size by Region
3.3.1 Global Oncology Injection Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Oncology Injection Drug Sales in Value by Region (2024-2029)
3.3.3 Global Oncology Injection Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oncology Injection Drug by Application
4.1 Oncology Injection Drug Market Segment by Application
4.1.1 Lymphoma
4.1.2 Myeloma
4.1.3 Prostate Cancer
4.1.4 Other
4.2 Global Oncology Injection Drug Market Size by Application
4.2.1 Global Oncology Injection Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Oncology Injection Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oncology Injection Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oncology Injection Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oncology Injection Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oncology Injection Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oncology Injection Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oncology Injection Drug Sales Breakdown by Application (2018-2023)
5 North America Oncology Injection Drug by Country
5.1 North America Oncology Injection Drug Historic Market Size by Country
5.1.1 North America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oncology Injection Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Oncology Injection Drug Sales in Value by Country (2018-2023)
5.2 North America Oncology Injection Drug Forecasted Market Size by Country
5.2.1 North America Oncology Injection Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Oncology Injection Drug Sales in Value by Country (2024-2029)
6 Europe Oncology Injection Drug by Country
6.1 Europe Oncology Injection Drug Historic Market Size by Country
6.1.1 Europe Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oncology Injection Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Oncology Injection Drug Sales in Value by Country (2018-2023)
6.2 Europe Oncology Injection Drug Forecasted Market Size by Country
6.2.1 Europe Oncology Injection Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Oncology Injection Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Oncology Injection Drug by Region
7.1 Asia-Pacific Oncology Injection Drug Historic Market Size by Region
7.1.1 Asia-Pacific Oncology Injection Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oncology Injection Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oncology Injection Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oncology Injection Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Oncology Injection Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oncology Injection Drug Sales in Value by Region (2024-2029)
8 Latin America Oncology Injection Drug by Country
8.1 Latin America Oncology Injection Drug Historic Market Size by Country
8.1.1 Latin America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oncology Injection Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oncology Injection Drug Sales in Value by Country (2018-2023)
8.2 Latin America Oncology Injection Drug Forecasted Market Size by Country
8.2.1 Latin America Oncology Injection Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oncology Injection Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Oncology Injection Drug by Country
9.1 Middle East and Africa Oncology Injection Drug Historic Market Size by Country
9.1.1 Middle East and Africa Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oncology Injection Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oncology Injection Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oncology Injection Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Oncology Injection Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oncology Injection Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Taj Oncology
10.1.1 Taj Oncology Company Information
10.1.2 Taj Oncology Introduction and Business Overview
10.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Taj Oncology Oncology Injection Drug Products Offered
10.1.5 Taj Oncology Recent Development
10.2 S.G. Biopharm
10.2.1 S.G. Biopharm Company Information
10.2.2 S.G. Biopharm Introduction and Business Overview
10.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 S.G. Biopharm Oncology Injection Drug Products Offered
10.2.5 S.G. Biopharm Recent Development
10.3 AdvaCare
10.3.1 AdvaCare Company Information
10.3.2 AdvaCare Introduction and Business Overview
10.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AdvaCare Oncology Injection Drug Products Offered
10.3.5 AdvaCare Recent Development
10.4 Merrimack
10.4.1 Merrimack Company Information
10.4.2 Merrimack Introduction and Business Overview
10.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merrimack Oncology Injection Drug Products Offered
10.4.5 Merrimack Recent Development
10.5 Celgene
10.5.1 Celgene Company Information
10.5.2 Celgene Introduction and Business Overview
10.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Celgene Oncology Injection Drug Products Offered
10.5.5 Celgene Recent Development
10.6 Allos Therapeutics
10.6.1 Allos Therapeutics Company Information
10.6.2 Allos Therapeutics Introduction and Business Overview
10.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Allos Therapeutics Oncology Injection Drug Products Offered
10.6.5 Allos Therapeutics Recent Development
10.7 Ferring Pharmaceuticals
10.7.1 Ferring Pharmaceuticals Company Information
10.7.2 Ferring Pharmaceuticals Introduction and Business Overview
10.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products Offered
10.7.5 Ferring Pharmaceuticals Recent Development
10.8 Genzyme
10.8.1 Genzyme Company Information
10.8.2 Genzyme Introduction and Business Overview
10.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Genzyme Oncology Injection Drug Products Offered
10.8.5 Genzyme Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Eli Lilly Oncology Injection Drug Products Offered
10.9.5 Eli Lilly Recent Development
10.10 Praecis Pharmaceuticals
10.10.1 Praecis Pharmaceuticals Company Information
10.10.2 Praecis Pharmaceuticals Introduction and Business Overview
10.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products Offered
10.10.5 Praecis Pharmaceuticals Recent Development
10.11 Millennium Pharmaceuticals
10.11.1 Millennium Pharmaceuticals Company Information
10.11.2 Millennium Pharmaceuticals Introduction and Business Overview
10.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Millennium Pharmaceuticals Oncology Injection Drug Products Offered
10.11.5 Millennium Pharmaceuticals Recent Development
10.12 Debiopharm
10.12.1 Debiopharm Company Information
10.12.2 Debiopharm Introduction and Business Overview
10.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Debiopharm Oncology Injection Drug Products Offered
10.12.5 Debiopharm Recent Development
10.13 Alza
10.13.1 Alza Company Information
10.13.2 Alza Introduction and Business Overview
10.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Alza Oncology Injection Drug Products Offered
10.13.5 Alza Recent Development
10.14 CordenPharma
10.14.1 CordenPharma Company Information
10.14.2 CordenPharma Introduction and Business Overview
10.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 CordenPharma Oncology Injection Drug Products Offered
10.14.5 CordenPharma Recent Development
10.15 Pharmascience
10.15.1 Pharmascience Company Information
10.15.2 Pharmascience Introduction and Business Overview
10.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Pharmascience Oncology Injection Drug Products Offered
10.15.5 Pharmascience Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oncology Injection Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oncology Injection Drug Industrial Chain Analysis
11.4 Oncology Injection Drug Market Dynamics
11.4.1 Oncology Injection Drug Industry Trends
11.4.2 Oncology Injection Drug Market Drivers
11.4.3 Oncology Injection Drug Market Challenges
11.4.4 Oncology Injection Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oncology Injection Drug Distributors
12.3 Oncology Injection Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock